Niagen CEO exercises 20,000 stock options
Niagen Bioscience Chief Executive Officer Robert N. Fried exercised stock options to acquire 20,000 shares of Common Stock at an exercise price of $2.61 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Niagen Bioscience Chief Executive Officer Robert N. Fried exercised stock options to acquire 20,000 shares of Common Stock at an exercise price of $2.61 per share. He paid the exercise price in cash and, according to the footnotes, has not sold any of the shares received.
Following the exercise, Fried directly holds 1,058,981 shares of Common Stock. He also reports indirect holdings through family-related accounts and trusts, including 12,746 shares held by his sons and additional shares held in separate irrevocable and revocable trusts, while disclaiming beneficial ownership of those indirect securities.
Insider Trade Summary
20,000 shares exercised/converted
Exercise
6 txns
Insider
Fried Robert N
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (right to buy) | 20,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 20,000 | $2.61 | $52K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Options (right to buy) — 0 contracts (Direct);
Common Stock — 1,058,981 shares (Direct);
Common Stock — 95,001 shares (Indirect, By Fried-Travis Revocable Trust U/A Dated 06/02/1999);
Common Stock — 250,000 shares (Indirect, By US Trust Co. of Delaware Trustee of The Jeremy W Fried 2020 Irrevocable Trust dated 02/26/2020);
Common Stock — 250,000 shares (Indirect, By US Trust Co. of Delaware Trustee of The Benjamin A Fried 2020 Irrevocable Trust dated 02/26/2020);
Common Stock — 12,746 shares (Indirect, See Footnote)
Footnotes (3)
- F1. The Reporting Person exercised the stock options reported on this Form 4 in advance of their expiration on November 15, 2026, paying the exercise price with cash, and has not sold any of the shares received upon exercise.
- F2. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- F3. 6,745 shares of Common Stock held by Jeremy Fried and 6,001 shares of Common Stock held by Benjamin Fried, who are sons of Robert Fried.
Key Figures
Options exercised: 20,000 shares
Exercise price: $2.61 per share
Direct holdings after exercise: 1,058,981 shares
+5 more
8 metrics
Options exercised
20,000 shares
Stock options exercised by CEO on 2026-04-24
Exercise price
$2.61 per share
Cash exercise of stock options
Direct holdings after exercise
1,058,981 shares
Common Stock directly held by CEO after transaction
Sons’ combined holdings
12,746 shares
Common Stock held by Jeremy and Benjamin Fried
Benjamin trust holdings
250,000 shares
Common Stock held by Benjamin A. Fried 2020 Irrevocable Trust
Jeremy trust holdings
250,000 shares
Common Stock held by Jeremy W. Fried 2020 Irrevocable Trust
Revocable trust holdings
95,001 shares
Common Stock held by Fried-Travis Revocable Trust
Exercised grant expiration
November 15, 2026
Original expiration date of exercised stock options
Key Terms
stock options, derivative security, beneficial ownership, Section 16, +2 more
6 terms
stock options financial
"The Reporting Person exercised the stock options reported on this Form 4 in advance of their expiration"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of these securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Section 16 regulatory
"shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
irrevocable trust financial
"Trustee of The Benjamin A Fried 2020 Irrevocable Trust dated 02/26/2020"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
revocable trust financial
"By Fried-Travis Revocable Trust U/A Dated 06/02/1999"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Niagen Bioscience (NAGE) report for its CEO?
Niagen Bioscience reported that CEO Robert N. Fried exercised stock options for 20,000 Common Stock shares. He paid the $2.61 per-share exercise price in cash and has not sold any of the shares received, indicating this was an exercise-and-hold transaction.
At what price did the Niagen (NAGE) CEO exercise his stock options?
Robert N. Fried exercised stock options at an exercise price of $2.61 per share. The options covered 20,000 shares of Common Stock, and a footnote states he paid the exercise price in cash rather than using a cashless method or selling shares.
What happened to the stock options exercised by the Niagen (NAGE) CEO?
The 20,000 stock options exercised by Robert N. Fried, with a $2.61 exercise price and a November 15, 2026 expiration, are now fully converted. The derivative position is reduced to zero for that grant, and he holds the underlying 20,000 Common Stock shares directly.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates